揭开囊性纤维化病跨膜导电性调节器调节器的真正价值
Aqeem Azam1,2, Andrew M Jones1,2, Peter J Barry1,2
1Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Wythenshawe, UK.
囊性纤维化跨膜导电调节器 (CFTR) 调节器具有显著的临床益处. 了解它们的真正价值对于优化治疗策略和改善囊性纤维化护理患者的治疗结果至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
背景情况:
- 囊性纤维化是一种由CFTR基因突变引起的遗传疾病.
- CFTR调节剂是一种旨在纠正缺陷CFTR蛋白的功能的一类药物.
研究的目的:
- 评估CFTR调节器的综合临床和经济价值.
- 提供当前CFTR调节器疗法的益处和局限性的深入分析.
主要方法:
- 对临床试验和现实世界的证据进行系统的文献审查.
- 对疗效和安全数据的元分析.
- 卫生经济建模以评估成本效益.
主要成果:
- CFTR调节器在肺功能和生活质量方面显著改善.
- 长期数据表明持续的益处和疾病修饰的潜力.
- 经济分析显示,符合条件的患者群体的成本效益比率有利.
结论:
- CFTR调节器代表了囊性纤维化治疗的变革性治疗方法.
- 基于特定CFTR突变的个性化治疗策略至关重要.
- 需要继续进行研究,以扩大CFTR突变的所有个体的获取和解决未满足需求.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
15:12Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
